Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bisacodyl (Halflytely) (1 trial)
clarithromycin (biaxin) (1 trial)
furazolidone (furoxone) (1 trial)
ilaprazole (noltec) (1 trial)
levofloxacin (levaquin) (1 trial)
metronidazole (flagyl) (1 trial)
polyethylene glycol (2 trials)
procaine benzylpenicillin (novocaine) (1 trial)
prucalopride (1 trial)
tegafur (1 trial)
tetracycline (tetrex) (1 trial)
tinidazole (tindamax) (1 trial)
vitamin c (1 trial)
cytarabine (cytosar-u) (1 trial)
decitabine (dacogen) (1 trial)
cyclosporine (sandimmune) (1 trial)
umbilical cord mesenchymal stem cells (1 trial)
bifidobacteria (1 trial)
ceftazidime (fortaz) (1 trial)
Disease Susceptibility (Phase 4)
Leukemia (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Trials (7 total)
Trial APIs (19 total)